摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-(2-(4-chlorophenoxy)-2-methylpropanamido)ethyl)docosa-4,7,10,13,16,19-hexaenamide | 1286174-13-7

中文名称
——
中文别名
——
英文名称
(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-(2-(4-chlorophenoxy)-2-methylpropanamido)ethyl)docosa-4,7,10,13,16,19-hexaenamide
英文别名
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-[[2-(4-chlorophenoxy)-2-methylpropanoyl]amino]ethyl]docosa-4,7,10,13,16,19-hexaenamide
(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-(2-(4-chlorophenoxy)-2-methylpropanamido)ethyl)docosa-4,7,10,13,16,19-hexaenamide化学式
CAS
1286174-13-7
化学式
C34H47ClN2O3
mdl
——
分子量
567.212
InChiKey
ONBWYOGDIIYXJP-YNUSHXQLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.2
  • 重原子数:
    40
  • 可旋转键数:
    20
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • METHODS OF LOWERING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
    申请人:Catabasis Pharmacauticals, Iinc.
    公开号:US20150344430A1
    公开(公告)日:2015-12-03
    The invention relates to new methods of modulating cholesterol by inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9) with fatty acid derivatives; and new methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid derivative. The present invention is also directed to fatty acid bioative derivatives and their use in the treatment of metabolic diseases.
    本发明涉及使用脂肪酸衍生物抑制前蛋白酶转化酶亚精氨酸/酶切割酶9 (PCSK9)来调节胆固醇的新方法;以及通过给予有效量的脂肪酸衍生物来治疗或预防代谢性疾病的新方法。本发明还涉及脂肪酸生物活性衍生物及其在治疗代谢性疾病中的应用。
  • [EN] FATTY ACID FIBRATE DERIVATIVES AND THEIR USES<br/>[FR] DÉRIVÉS DE FIBRATES ET D'ACIDES GRAS ET LEURS UTILISATIONS
    申请人:CATABASIS PHARMACEUTICALS INC
    公开号:WO2011044141A1
    公开(公告)日:2011-04-14
    The invention relates to fatty acid fibrate derivatives; compositions comprising an effective amount of a fatty acid fibrate derivative; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid fibrate derivative.
  • FATTY ACID FIBRATE DERIVATIVES AND THEIR USES
    申请人:Milne Jill C.
    公开号:US20110082210A1
    公开(公告)日:2011-04-07
    The invention relates to fatty acid fibrate derivatives; compositions comprising an effective amount of a fatty acid fibrate derivative; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid fibrate derivative.
    该发明涉及脂肪酸纤维酸衍生物;包含有效量脂肪酸纤维酸衍生物的组合物;以及治疗或预防代谢性疾病的方法,包括给予有效量脂肪酸纤维酸衍生物的管理。
查看更多